新合成経口抗菌剤DL-8280の新鮮臨床分離株に対する<I>in vitro</I>抗菌作用
書誌事項
- タイトル別名
-
- THE <I>IN VITRO</I> ACTIVITY OF DL-8280 AGAINST CLINICAL ISOLATES OF GRAM-POSITIVE AND NEGATIVE BACTERIA
抄録
The in vitro activity of DL-8280 was compared with the activities of norfloxacin (NFLX), pipemidic acid (PPA), piromidic acid (PA) and nalidixic acid (NA) against clinical bacterial isolates. DL-8280 was found to be 10-100 times more active than PPA, PA or NA against S. aureus and S. faecalis. NFLX was also active, but slightly less active than DL-8280.<BR>Against E. coli, P. aeruginosa and S. marcescens, DL-8280 was more active than PPA, PA or NA, but slightly less active than NFLX. The growth of N. gonorrhoeae including penicillin resistant strains were completely inhibited by≤0.10μ/ml of DL-8280.
収録刊行物
-
- ＣＨＥＭＯＴＨＥＲＡＰＹ
-
ＣＨＥＭＯＴＨＥＲＡＰＹ 32 (Supplement1), 84-89, 1984
公益社団法人 日本化学療法学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681260090496
-
- NII論文ID
- 130004071893
-
- ISSN
- 18845894
- 00093165
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可